Goncalves Joana Insider Trading Activity
Goncalves Joana has been net-selling over the last 12 months with 0 purchases and 18 sales across 1 company.
ORKA is the most-traded position with 18 trades. The largest single transaction was a sale of ORKA for $295K on May 15, 2026.
Performance Scorecard
Forward stock performance after each transaction by Goncalves Joana. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -18.5% | 17% | 18 |
| 90 days | — | -56.7% | 0% | 15 |
| 120 days | — | -116.7% | 0% | 12 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersORKA · Oruka Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Goncalves Joana bought and sold ORKA.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 15, 2026 | ORKA | Sell | 4,800 | $61.56 | $295K | −11.9% | Chief Medical Officer | |
May 15, 2026 | ORKA | Sell | 2,100 | $62.42 | $131K | −5.9% | Chief Medical Officer | |
May 15, 2026 | ORKA | Sell | 100 | $63.52 | $6K | −0.3% | Chief Medical Officer | |
Apr 15, 2026 | ORKA | Sell | 4,227 | $65.73 | $278K | −10.5% | Chief Medical Officer | |
Apr 15, 2026 | ORKA | Sell | 2,273 | $66.56 | $151K | −6.3% | Chief Medical Officer | |
Apr 15, 2026 | ORKA | Sell | 500 | $67.38 | $34K | −1.5% | Chief Medical Officer | |
Mar 16, 2026 | ORKA | Sell | 2,921 | $40.11 | $117K | −7.1% | Chief Medical Officer | |
Mar 16, 2026 | ORKA | Sell | 2,902 | $41.20 | $120K | −7.6% | Chief Medical Officer | |
Mar 16, 2026 | ORKA | Sell | 1,177 | $41.94 | $49K | −3.3% | Chief Medical Officer | |
Mar 16, 2026 | ORKA | Sell | 641 | $41.30 | $26K | −1.9% | Chief Medical Officer | |
Feb 17, 2026 | ORKA | Sell | 6,064 | $32.30 | $196K | −14.8% | Chief Medical Officer | |
Feb 17, 2026 | ORKA | Sell | 936 | $32.78 | $31K | −2.7% | Chief Medical Officer | |
Jan 15, 2026 | ORKA | Sell | 4,381 | $31.56 | $138K | −51.4% | Chief Medical Officer | |
Jan 15, 2026 | ORKA | Sell | 2,619 | $32.24 | $84K | −63.3% | Chief Medical Officer | |
Dec 19, 2025 | ORKA | Sell | 641 | $28.53 | $18K | −7.5% | Chief Medical Officer | |
Dec 19, 2025 | ORKA | Sell | 1,787 | $29.62 | $53K | −22.7% | Chief Medical Officer | |
Dec 19, 2025 | ORKA | Sell | 1,492 | $30.70 | $46K | −24.5% | Chief Medical Officer | |
Dec 19, 2025 | ORKA | Sell | 3,080 | $31.58 | $97K | −67.0% | Chief Medical Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | 18 | $1.9M |
Other insiders at Oruka Therapeutics, Inc.
3 other tracked filers at ORKA.